ArriVent BioPharma Names Winston Kung as CFO Ahead of IPO
By Will Feuer ArriVent BioPharma named Winston Kung, the former chief operating officer and chief financial officer of PMV Pharmaceuticals, its next CFO...
Source: marketwatch.com
Stay updated with breaking news from Corporate Changes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Will Feuer ArriVent BioPharma named Winston Kung, the former chief operating officer and chief financial officer of PMV Pharmaceuticals, its next CFO...
Sarah Personette will be tasked with helping company expand into new coverage areas and markets
Kazakh fintech is profitable and revenue is growing.
After two years with few deals, the IPO market is expected to bounce back this year.
By Ben Glickman Boustead Wavefront requested the withdrawal of its initial public offering filing with the Securities and Exchange Commission. The company...